OMDA — Omada Health, Inc. Stock Price, Chart & AI Report

Neutral Jan 24, 2026 • 17:03 UTC The Motley Fool • Jonathan Ponciano

Voyager Stock Up 12% Post-IPO as One Fund Commits Nearly 30% of Assets

Liberty Street Advisors increased its stake in Voyager Technologies (VOYG) by 136,925 shares worth $3.71 million, bringing the company to nearly 30% of the fund's assets. Voyager's stock has risen 12% since its IPO at $31, now trading at $34.58. The investment reflects confidence in Voyager's defense and space technology business, supported by strong Q3 results including 31% growth in its Defense segment, $188.6 million backlog, and $413 million in cash with no debt.

VOYG OMDA aerospace and defense IPO institutional investment defense systems space technology backlog growth

Sentiment note

Mentioned only as a holding in Liberty Street Advisors' portfolio (5.8% of AUM) with no specific news or performance commentary provided in the article.

Positive Dec 4, 2025 • 01:45 UTC GlobeNewswire Inc. • Sns Insider

Digital Health Coaching Market Size Worth $28.40 Billion by 2032, Drive by AI-Driven Personalization and Rising Demand for Preventive Care – SNS Insider

The digital health coaching market is projected to grow from $11.03 billion in 2024 to $28.40 billion by 2032, driven by AI-powered personalization, rising chronic disease rates, and increased employer wellness program adoption.

OMDA digital health coaching AI personalization preventive care chronic disease management wellness programs

Sentiment note

Launched innovative AI-driven nutritional intelligence platform, showing technological advancement

Positive Nov 4, 2025 • 17:00 UTC GlobeNewswire Inc. • Omada Health

Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users

Omada Health presented research at ObesityWeek 2025 showing its behavior change program can enhance weight loss outcomes and medication persistence for GLP-1 users, with members maintaining weight loss even after discontinuing medication.

OMDA GLP-1 weight loss obesity healthcare medication persistence

Sentiment note

The company demonstrated positive research outcomes showing its program can improve weight loss persistence and maintenance, potentially increasing its value proposition in healthcare

Positive Oct 1, 2025 • 13:00 UTC GlobeNewswire Inc. • Rose Ramseth

Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting

Omada Health introduces Meal Map, an AI nutrition tool focusing on nutrient quality instead of calorie counting, aiming to help members make informed food choices and develop healthier eating habits.

OMDA AI nutrition nutrient density health technology personalized nutrition

Sentiment note

Launched innovative AI-powered nutrition tool demonstrating technological advancement, member engagement, and commitment to holistic health approaches

Positive Aug 28, 2025 • 13:00 UTC GlobeNewswire Inc. • Omada Health

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

Omada Health's virtual physical therapy program for musculoskeletal conditions showed lower healthcare utilization and spending compared to in-person physical therapy, with median per-member savings over $100 in the first six months.

OMDA virtual physical therapy musculoskeletal conditions healthcare costs digital health

Sentiment note

The study demonstrated significant cost savings, reduced healthcare utilization, and a positive return on investment (ROI) for their virtual physical therapy program

Positive Jun 17, 2025 • 13:00 UTC GlobeNewswire Inc. • N/A

Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

Omada Health's GLP-1 companion program significantly improved persistence rates for GLP-1 medications, helping members achieve clinical trial-level weight loss outcomes in real-world settings.

OMDA GLP-1 medication persistence weight loss real-world outcomes

Sentiment note

The article highlights Omada Health's successful GLP-1 companion program, which improved medication persistence and helped members achieve better weight loss outcomes compared to real-world data. This suggests the company's program is effective in supporting patients and delivering positive results.